Clinical trial
Family-partnered Delirium Prevention, Detection, and Management in the ICU: A Stepped-wedge Cluster Randomized Trial
NCT07896356 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.
Follow this trial by email Email me the PDF
Summary
Not yet recruiting, started February 2027. Interventional study, 1,344 participants (estimated). Lead sponsor University of Calgary; Canada. Primary measure: Family member symptoms of depression and anxiety.
How it compares
333 similar trials: same condition (Delirium) and phase
Registry record
As filed in ClinicalTrials.gov.
- Title
- Family-partnered Delirium Prevention, Detection, and Management in the ICU: A Stepped-wedge Cluster Randomized Trial
- Lead sponsor
- University of Calgary
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 1, 2027
- Completion date
- February 1, 2030
- Enrollment
- 1,344 (estimated)
- Sites
- 1
Conditions
MeSH condition names; the registry's own terms follow.
Registry terms: intensive care unit delirium, post intensive care unit syndrome, post intensive care unit syndrome family
Who could take part, where it ran, who ran it
As filed in ClinicalTrials.gov.
- Sex
- All
- Minimum age
- 18 Years
- Healthy volunteers
- No
- Study type
- Interventional
- Sites
- 1
- Countries
- Canada
- Lead sponsor
- University of Calgary
Arms
As registered; 2 arms.
| Arm | Type | Interventions |
|---|---|---|
| Control Group | Placebo comparator | Standard of Care |
Show registry wordingPatients and family caregivers will receive standard of care, which varies by study site, but includes guideline-recommended interventions by the clinical team to prevent and manage delirium. | ||
| Intervention Group | Experimental | Delirium Education, Prevention, and Management, Standard of Care |
Show registry wordingPatients and family caregivers will receive standard of care, which varies by study site, but includes guideline-recommended interventions by the clinical team to prevent and manage delirium. Additionally, they will receive a family-partnered delirium care intervention comprised of two components: 1) Education and 2) Family administered delirium prevention, detection, and management activities. | ||
Primary endpoints
Registered primary outcome measures; 1 primary.
| Measure | Time frame |
|---|---|
| Family member symptoms of depression and anxiety | 3-months post-ICU discharge |
Show registry wordingChange in the proportion of major depressive disorder and generalized anxiety symptamology in family members of critical ill patients measured by the Patient Health Questionnaire-Anxiety and Depression Scale (PHQ-ADS) scores, compared between control and intervention | |
Lead sponsor's other trials
University of Calgary, most recent start first.
+697 more trials See the organization page
Similar trials
Same condition (Delirium) and phase, most recent start first.
+328 more trials See the condition page